Why it matters:
Lidocaine plasters are licensed for symptomatic relief of neuropathic pain associated with previous herpes zoster infection (PHN) in adults.
NICE guidance on chronic pain does not recommend lidocaine plasters for treating neuropathic pain.
The joint clinical working group also considered a PrescQIPP CIC review, and during the consultation more evidence was provided and an up to date evidence summary was deemed necessary and prepared by the Specialist Pharmacy Service to inform the joint clinical working group’s recommendations. Based on this review, lidocaine plasters can be prescribed only for patients who are intolerant of first-line systemic therapies for PHN or where these therapies have been ineffective.
Lidocaine plasters are not an alternative to an opioid-based medicine when concerned about dependence and withdrawal.
For guidance on when prescribing may be appropriate in some exceptional circumstances, please see the full NHS England guidance document.
Description: Cost of lidocaine plasters per 1000 patients
Performance: Loading...
Explore:
Tagged as: Cost Saving, Efficacy, NHS England - items which should not routinely be prescribed in primary care, NICE, Pain (or browse all measures)
Sub-ICB Locations are ordered by mean percentile over the past six months. Each chart shows the results for the individual Sub-ICB Location, plus deciles across all Sub-ICB Locations in the NHS in England.
View measure for NHS England combined →